Trial Profile
Computed tomography and finite element analysis using romosozumab in patients with low bone mineral density
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Nov 2016
Price :
$35
*
At a glance
- Drugs Romosozumab (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- 14 Nov 2016 New trial record